Effect of Caloric Restriction on Myocardial Fatty Acid Uptake, Left Ventricular Mass, and Cardiac Work in Obese Adults
Obesity is associated with increased fatty acid uptake in the myocardium, and this may have deleterious effects on cardiac function. The aim of this study was to evaluate how weight loss influences myocardial metabolism and cardiac work in obese adults. Thirty-four obese (mean body mass index 33.7 ± 0.7 kg/m2) but otherwise healthy subjects consumed a very low calorie diet for 6 weeks. Cardiac substrate metabolism and work were measured before and after the diet. Myocardial fatty acid uptake was measured in 18 subjects using fluorine-18-fluoro-6-thia-heptadecanoic acid and positron emission tomography, and myocardial glucose uptake was measured in 16 subjects using fluorine-18-2-fluoro-2-deoxyglucose. Myocardial structure and cardiac function were measured using magnetic resonance imaging. Consumption of the very low calorie diet decreased weight (−11.2 ± 0.6 kg, p <0.0001). Myocardial fatty acid uptake decreased from 4.2 ± 0.4 to 2.9 ± 0.2 μmol/100 g/min (p <0.0001). Myocardial mass decreased by 7% (p <0.005), and cardiac work decreased by 26% (p <0.0001). Whole-body insulin sensitivity increased by 33% (p <0.01), but insulin-stimulated myocardial glucose uptake remained unchanged (p = 0.90). Myocardial triglyceride content decreased by 31% (n = 8, p = 0.076). In conclusion, weight reduction decreases myocardial fatty acid uptake in parallel with myocardial mass and cardiac work. These results show that the increased fatty acid uptake found in the hearts of obese patients can be reversed by weight loss.
To access this article, please choose from the options below
This work was supported by grants and funding from the HEPADIP EU FP6 program, Copenhagen University Hospital, Copenhagen, Denmark, the Novo Nordisk Foundation, Gentofte, Denmark, the Yrjö Jahnsson Foundation, Helsinki, Finland, the Juho Vainio Foundation, Helsinki, Finland, the Finnish Diabetes Foundation, Helsinki, Finland, the Orion Group Research Foundation, Helsinki, Finland, the Aarne Koskelo Foundation, Espoo, Finland, the Finnish Medical Society Duodecim, Helsinki, Finland, the EFSD/Eli-Lilly fellowship in diabetes and metabolism, Düsseldorf, Germany, and the Hospital District of Southwest Finland, Turku, Finland. The study was conducted within the Centre of Excellence in Molecular Imaging in Cardiovascular and Metabolic Research, supported by the Academy of Finland, Helsinki, Finland, University of Turku, Helsinki, Finland, Turku University Hospital, Helsinki, Finland, and Abo Academy, Helsinki, Finland.
PII: S0002-9149(09)00606-7
doi:10.1016/j.amjcard.2009.02.025
© 2009 Elsevier Inc. All rights reserved.
